retatrutide drug retatrutide clinical trials trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II The results of the drug – retatrutide clinical trial results retatrutide

US$ 20.61

★★★★★ 4.9 (29 reviews)

US$ 22.81

★★★★★ 4.1 (8 reviews)

US$ 25.35

★★★★★ 4.1 (11 reviews)

US$ 20.51

★★★★★ 4.2 (14 reviews)

US$ 20.50

★★★★★ 5.0 (16 reviews)

US$ 28.86

★★★★★ 4.9 (25 reviews)

US$ 25.17

★★★★★ 5.0 (23 reviews)

US$ 24.84

★★★★★ 4.3 (9 reviews)

US$ 24.82

★★★★★ 4.0 (23 reviews)

US$ 25.65

★★★★★ 4.1 (11 reviews)

US$ 20.89

★★★★★ 4.7 (27 reviews)

US$ 20.56

★★★★★ 4.4 (27 reviews)

US$ 24.53

★★★★★ 4.9 (18 reviews)

US$ 25.74

★★★★★ 4.7 (29 reviews)

US$ 28.33

★★★★★ 4.5 (8 reviews)

US$ 20.34

★★★★★ 4.5 (6 reviews)

US$ 29.69

★★★★★ 5.0 (14 reviews)

US$ 27.63

★★★★★ 4.4 (15 reviews)

US$ 28.54

★★★★★ 4.7 (8 reviews)

US$ 25.13

★★★★★ 4.8 (24 reviews)